FR-180204

SynDRA canonical compound SYN1969673 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	MAPK1 \| MAPK3
Mechanism of action	MAP kinase inhibitor

All known targets

MAPK1
MAPK3

Mechanisms of action (all sources)

MEK inhibitor

Cross-references

Synonyms

FR 180204
FR180204
ERK Inhibitor II, FR180204
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine
CHEMBL259551
5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE
C18H13N7
5-{2-phenylpyrazolo[1,5-a]pyridin-3-yl}-1H-pyrazolo[3,4-c]pyridazin-3-amine
5-{2-phenylpyrazolo[1,5-a]pyridin-3-yl}-2H-pyrazolo[3,4-c]pyridazin-3-amine
5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-2H-pyrazolo[3,4-c]pyridazin-3-amine
ERK inhibitor II
MLS002607685

Look up FR-180204 in the interactive SynDRA portal →